Next week, HC Andersen Capital will be hosting a webinar on Zerion Pharma where our CEO Ole Wiborg and CFO Jakob Dynnes Hansen will introduce the company.
The webinar is an online event that will be held on 01 February 2023 11:00 - 11:30.
Register by clicking on the link: https://hcandersencapital.dk/event/zerion-pharma-company-introduction/
ZERION has developed the Dispersome® platform technology that improves the solubility of poorly soluble oral drugs and improves bioavailability and therapeutic options for patients. The Dispersome® technology is based on the production of stable amorphous formulations by mixing high amounts of drug substance with beta-lactoglobulin supplied by Arla Food Ingredients. The Dispersome® technology is patent protected.
